Phase I/II Study of Docetaxel, Cisplatin and 5-Fluorouracil(TPF) as 1st-Line Chemotherapy in Patients With Metastatic Esophageal Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 25 May 2010
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 25 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2009 Planned end date changed from 1 Nov 2008 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 16 Oct 2005 New trial record.